VCYT Valuation

Veracyte Inc

Add to Watchlist

Advanced Chart

30.350

+0.13(0.430%)1D

Overview
Forecast
Valuation
Earnings

VCYT Relative Valuation

VCYT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, VCYT is overvalued; if below, it's undervalued.

Historical Valuation

Veracyte Inc (VCYT) is now in the Fair zone, suggesting that its current forward PS ratio of 4.55 is considered Fairly compared with the five-year average of -21.41. The fair price of Veracyte Inc (VCYT) is between 22.21 to 73.53 according to relative valuation methord.

Relative Value

Fair Zone

22.21-73.53

Current Price：30.35

Fair

23.24

Trailing

Forward

17.97

EV/EBITDA

Veracyte Inc. (VCYT) has a current EV/EBITDA of 17.97. The 5-year average EV/EBITDA is -58.71. The thresholds are as follows: Strongly Undervalued below -353.28, Undervalued between -353.28 and -206.00, Fairly Valued between 88.58 and -206.00, Overvalued between 88.58 and 235.87, and Strongly Overvalued above 235.87. The current Forward EV/EBITDA of 17.97 falls within the Historic Trend Line -Fairly Valued range.

43.56

EV/EBIT

Veracyte Inc. (VCYT) has a current EV/EBIT of 43.56. The 5-year average EV/EBIT is 92.79. The thresholds are as follows: Strongly Undervalued below -790.71, Undervalued between -790.71 and -348.96, Fairly Valued between 534.55 and -348.96, Overvalued between 534.55 and 976.30, and Strongly Overvalued above 976.30. The current Forward EV/EBIT of 43.56 falls within the Historic Trend Line -Fairly Valued range.

4.55

Veracyte Inc. (VCYT) has a current PS of 4.55. The 5-year average PS is 7.83. The thresholds are as follows: Strongly Undervalued below -1.78, Undervalued between -1.78 and 3.02, Fairly Valued between 12.63 and 3.02, Overvalued between 12.63 and 17.44, and Strongly Overvalued above 17.44. The current Forward PS of 4.55 falls within the Historic Trend Line -Fairly Valued range.

23.74

P/OCF

Veracyte Inc. (VCYT) has a current P/OCF of 23.74. The 5-year average P/OCF is -1224.61. The thresholds are as follows: Strongly Undervalued below -11376.28, Undervalued between -11376.28 and -6300.44, Fairly Valued between 3851.23 and -6300.44, Overvalued between 3851.23 and 8927.06, and Strongly Overvalued above 8927.06. The current Forward P/OCF of 23.74 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Veracyte Inc. (VCYT) has a current P/FCF of 0.00. The 5-year average P/FCF is -23.88. The thresholds are as follows: Strongly Undervalued below -219.80, Undervalued between -219.80 and -121.84, Fairly Valued between 74.08 and -121.84, Overvalued between 74.08 and 172.04, and Strongly Overvalued above 172.04. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Veracyte Inc (VCYT) has a current Price-to-Book (P/B) ratio of 1.95. Compared to its 3-year average P/B ratio of 1.81 , the current P/B ratio is approximately 7.44% higher. Relative to its 5-year average P/B ratio of 2.62, the current P/B ratio is about -25.77% higher. Veracyte Inc (VCYT) has a Forward Free Cash Flow (FCF) yield of approximately 3.55%. Compared to its 3-year average FCF yield of 1.44%, the current FCF yield is approximately 146.60% lower. Relative to its 5-year average FCF yield of 0.44% , the current FCF yield is about 710.56% lower.

1.95

P/B

Median3y

1.81

Median5y

2.62

3.55

FCF Yield

Median3y

1.44

Median5y

0.44

Competitors Valuation Multiple

The average P/S ratio for VCYT's competitors is 3.96, providing a benchmark for relative valuation. Veracyte Inc Corp (VCYT) exhibits a P/S ratio of 4.55, which is 14.74% above the industry average. Given its robust revenue growth of 13.75%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Alphatec Holdings Inc

Procept Biorobotics Corp

LeMaitre Vascular Inc

Performance Decomposition

Market capitalization of VCYT decreased by 4.22% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 45.70 to 90.02.

The secondary factor is the Revenue Growth, contributed 13.75%to the performance.

Overall, the performance of VCYT in the past 1 year is driven by P/E Change. Which is more unsustainable.

13.75%

114.43M → 130.16M

Revenue Growth

-114.97%

5.01 → -0.75

Margin Expansion

97.00%

45.70 → 90.02

P/E Change

-4.22%